Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

RBC Capital Maintains Outperform on Thermo Fisher Scientific, Raises Price Target to $664

Author: Benzinga Newsdesk | July 25, 2024 01:05pm
RBC Capital analyst Conor McNamara maintains Thermo Fisher Scientific (NYSE:TMO) with a Outperform and raises the price target from $660 to $664.

Posted In: TMO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist